These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 10766244)

  • 1. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
    Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.
    Mao Y; Jin J; Daniel JL; Kunapuli SP
    Platelets; 2009 May; 20(3):191-8. PubMed ID: 19437337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thrombin signalling in platelets in haemostasis and thrombosis.
    Sambrano GR; Weiss EJ; Zheng YW; Huang W; Coughlin SR
    Nature; 2001 Sep; 413(6851):74-8. PubMed ID: 11544528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H; Sturgeon SA; Jackson SP; Hamilton JR
    Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.
    Arachiche A; de la Fuente M; Nieman MT
    PLoS One; 2013; 8(2):e55740. PubMed ID: 23405206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L; Misra M; Badar J; Singh C; Kuliopulos A
    Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
    Nieman MT
    Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
    J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
    Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
    Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
    Altrogge LM; Monard D
    Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.